About Metabolomic Diagnostics
Metabolomic Diagnostics is a company based in Cork (Ireland) founded in 2011.. Metabolomic Diagnostics has raised $3.89 million across 7 funding rounds from investors including Enterprise Ireland, European Union and EIC Fund. Metabolomic Diagnostics offers products and services including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions. Metabolomic Diagnostics operates in a competitive market with competitors including Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others.
- Headquarter Cork, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.89 M (USD)
in 7 rounds
-
Latest Funding Round
$60.68 K (USD), Grant
Jan 31, 2021
-
Investors
Enterprise Ireland
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Metabolomic Diagnostics
Metabolomic Diagnostics offers a comprehensive portfolio of products and services, including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for identifying and translating biomarkers into clinical assays
Tools for multiplexing biomarkers in disease diagnostics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Metabolomic Diagnostics
Metabolomic Diagnostics has successfully raised a total of $3.89M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $60.68 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $60,681
-
First Round
First Round
(03 Jan 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Grant - Metabolomic Diagnostics | Valuation |
investors |
|
| Nov, 2018 | Amount | Grant - Metabolomic Diagnostics | Valuation |
investors |
|
| Jun, 2018 | Amount | Grant - Metabolomic Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Metabolomic Diagnostics
Metabolomic Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Metabolomic Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Metabolomic Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Metabolomic Diagnostics Comparisons
Competitors of Metabolomic Diagnostics
Metabolomic Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fertility decisions are optimized using data analytics and genomics.
|
|
| domain | founded_year | HQ Location |
Provider of DNA and hormone analysis based birth control optimization kits
|
|
| domain | founded_year | HQ Location |
Disposable paper pregnancy test kits
|
|
| domain | founded_year | HQ Location |
Clinical-grade diagnostic tests for home use are developed.
|
|
| domain | founded_year | HQ Location |
Exosome-based diagnostic products for health screening are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Metabolomic Diagnostics
Frequently Asked Questions about Metabolomic Diagnostics
When was Metabolomic Diagnostics founded?
Metabolomic Diagnostics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Metabolomic Diagnostics located?
Metabolomic Diagnostics is headquartered in Cork, Ireland.
Is Metabolomic Diagnostics a funded company?
Metabolomic Diagnostics is a funded company, having raised a total of $3.89M across 7 funding rounds to date. The company's 1st funding round was a Grant of $205.2K, raised on Jan 03, 2014.
What does Metabolomic Diagnostics do?
Metabolomic Diagnostics was founded in 2011 in Cork, Ireland, where diagnostics and prognostics for maternal health are developed through metabolic profiling. Focus is placed on an early pregnancy test that identifies pre-eclampsia risk by analyzing panels of implicated metabolites. Operations include a subsidiary, Inform Bioscience, within the healthcare diagnostics sector.
Who are the top competitors of Metabolomic Diagnostics?
Metabolomic Diagnostics's top competitors include Celmatix, LIA Diagnostics and adyn.
What products or services does Metabolomic Diagnostics offer?
Metabolomic Diagnostics offers Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions.
Who are Metabolomic Diagnostics's investors?
Metabolomic Diagnostics has 6 investors. Key investors include Enterprise Ireland, European Union, EIC Fund, SOSV, and AIB Seed Capital Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.